The Angiotensin-melatonin axis

Luciana A Campos1, Jose Cipolla-Neto, Fernanda G Amaral

  • 1Center of Innovation, Technology and Education-(CITE), Camilo Castelo Branco University (UNICASTELO), São José dos Campos Technology Park, Presidente Dutra Road Km 138, 12247-004 São José dos Campos, SP, Brazil.

Insights

Disrupted circadian rhythms are linked to cardiovascular and metabolic diseases. Angiotensin II and melatonin may regulate these rhythms, offering potential for new chronotherapeutic strategies.

Area of Science:

  • Neuroendocrinology
  • Cardiovascular Science
  • Metabolic Science

Background:

  • Circadian rhythm disruptions are implicated in cardiovascular and metabolic disorders.
  • The brain renin-angiotensin system (RAS) and melatonin are key neurohormones involved in circadian regulation.
  • Existing treatments for hypertension and diabetes mellitus (DM) target the RAS.

Purpose of the Study:

  • To investigate the role of angiotensin II and melatonin in modulating circadian rhythms.
  • To explore the potential of combined RAS blockade and melatonin therapy for metabolic disorders.
  • To examine the interaction between neurohormones and clock genes in circadian regulation.

Main Methods:

  • Review of accumulating evidence on circadian rhythms, RAS, and melatonin.
  • Analysis of the impact of central nervous system angiotensin production on blood pressure circadian rhythms.
  • Consideration of melatonin's effects on metabolic abnormalities in DM and insulin resistance.

Main Results:

  • The brain RAS may modulate melatonin synthesis, influencing circadian rhythms.
  • Angiotensin II in the central nervous system affects both hypertension and blood pressure circadian rhythms.
  • Melatonin can ameliorate metabolic abnormalities in DM and insulin resistance.

Conclusions:

  • Combined RAS blockade and melatonin therapy may enhance treatment efficacy for cardiovascular and metabolic disorders.
  • Understanding the interaction between neurohormones and clock genes is crucial for advancing chronotherapeutics.
  • Further research into these interactions could reveal new pathophysiological insights and treatment strategies.

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
The Pineal Gland01:02

The Pineal Gland

The pineal gland, a diminutive endocrine structure named for its pinecone-shaped appearance, is situated atop the third ventricle within the diencephalon region of the forebrain. This gland, composed of secretory cells known as pinealocytes arranged in compact cords and clusters around dense particles of calcium salts, plays a pivotal role in hormonal regulation.
The primary secretion of the pineal gland is the hormone melatonin, derived from serotonin. The concentration of melatonin in the...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...